Camilla Zuckero | Executive Director of IR & Corporate Communications |
Derek Maetzold | Founder, President & CEO |
Frank Stokes | CFO |
Mason Carrico | Stephens |
Tom Peterson | Baird |
Puneet Souda | SVB Leerink |
Good afternoon, and welcome to the Castle Biosciences Second Quarter 2022 Conference Call.
As a reminder, today’s call is being recorded.
We will begin today's call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call over to Camilla Zuckero, Vice President, Investor Relations and Corporate Affairs. Please go ahead.